Tianjin ConjuStar Biologics Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Tianjin ConjuStar Biologics Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| SC-101 in Subjects With Advanced NECTIN4-Amplified Cancers (NCT07080619) | Tianjin ConjuStar Biologics Co., Ltd. | 2025-09-20 |
| Study of SC-102 in Patients With Advanced Solid Tumors (NCT06710158) | Tianjin ConjuStar Biologics Co., Ltd. | 2024-12-05 |
| Study SC-101 in Subjects With Advanced Malignancies (NCT06220838) | Tianjin ConjuStar Biologics Co., Ltd. | 2024-02-02 |
Track Tianjin ConjuStar Biologics Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.